Juan Ramon Alaix Sells 135,000 Shares of Zoetis Inc (ZTS) Stock  Caroline Horne | Aug 17th, 2018
Zoetis Inc (NYSE:ZTS) CEO Juan Ramon Alaix sold 135,000 shares of the company's stock in a transaction that occurred on Tuesday, August 14th. The shares were sold at an average price of $91.55, for a total value of $12,359,250.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link .
ZTS stock opened at $91.54 on Friday. Zoetis Inc has a 1-year low of $60.44 and a 1-year high of $93.67. The company has a market capitalization of $44.18 billion, a PE ratio of 38.14, a P/E/G ratio of 1.88 and a beta of 1.02. The company has a debt-to-equity ratio of 2.50, a quick ratio of 2.92 and a current ratio of 4.38. Get Zoetis alerts:
Zoetis (NYSE:ZTS) last announced its earnings results on Thursday, August 2nd. The company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.71 by $0.06. The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.38 billion. Zoetis had a return on equity of 72.30% and a net margin of 19.95%. Zoetis's revenue was up 11.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.53 EPS. analysts forecast that Zoetis Inc will post 3.07 earnings per share for the current year.
Several equities research analysts have recently weighed in on ZTS shares. Cantor Fitzgerald reiterated a "buy" rating and issued a $98.00 price objective on shares of Zoetis in a research note on Wednesday, May 16th. Craig Hallum reiterated a "buy" rating and issued a $94.00 price objective (up from $87.00) on shares of Zoetis in a research note on Wednesday, April 25th. Bank of America upped their price objective on Zoetis from $97.00 to $100.00 and gave the company a "buy" rating in a research note on Monday, July 30th. Jefferies Financial Group set a $96.00 price objective on Zoetis and gave the company a "buy" rating in a research note on Friday, July 13th. Finally, Citigroup reiterated a "buy" rating and issued a $98.00 price objective (up from $85.00) on shares of Zoetis in a research note on Thursday, April 19th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and twelve have issued a buy rating to the company. The company has a consensus rating of "Buy" and an average price target of $90.53.
Several institutional investors and hedge funds have recently made changes to their positions in the company. Schroder Investment Management Group boosted its holdings in shares of Zoetis by 30.4% in the 2nd quarter. Schroder Investment Management Group now owns 139,058 shares of the company's stock worth $11,797,000 after acquiring an additional 32,380 shares in the last quarter. Carnegie Capital Asset Management LLC boosted its holdings in shares of Zoetis by 2.2% in the 2nd quarter. Carnegie Capital Asset Management LLC now owns 168,008 shares of the company's stock worth $15,354,000 after acquiring an additional 3,667 shares in the last quarter. Private Wealth Partners LLC boosted its holdings in shares of Zoetis by 5.5% in the 2nd quarter. Private Wealth Partners LLC now owns 78,018 shares of the company's stock worth $6,646,000 after acquiring an additional 4,047 shares in the last quarter. Tiedemann Advisors LLC acquired a new position in shares of Zoetis in the 2nd quarter worth approximately $853,000. Finally, Verition Fund Management LLC boosted its holdings in shares of Zoetis by 29.3% in the 2nd quarter. Verition Fund Management LLC now owns 24,379 shares of the company's stock worth $2,077,000 after acquiring an additional 5,519 shares in the last quarter. 90.98% of the stock is currently owned by institutional investors and hedge funds.
Zoetis Company Profile
Zoetis Inc discovers, develops, manufactures, and markets veterinary vaccines and medicines in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. Zoetis Zoeti